pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Study finds AI may be driving up healthcare costs

Oct 1, 2026·read at Endpoints ↗Negative

A recent analysis by the Blue Cross Blue Shield Association challenges the common belief that artificial intelligence will lower healthcare spending.

The report argues that, instead of delivering savings, AI tools are contributing to higher expenses across the system.

The association points to factors such as increased diagnostic testing, implementation costs, and workflow changes as reasons for the cost rise.

The findings suggest that stakeholders should reassess expectations for AI-driven efficiencies in the near term.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Is AI jacking up healthcare costs?”

read at Endpoints ↗
74 words · retrieved 45m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoUnited Therapeutics' legal victory; BMS' Camzyos approved for kidsEndpoints
  • 3h agoLilly pulls back from Foghorn's synthetic lethality work as biotech sheds 40% of staffEndpoints
  • 3h ago#EASD26: Regeneron's antibody helps patients regain muscle after stopping GLP-1 therapyEndpoints
  • 3h agoQ&A: Anthropic's life sciences team talk Claude's first scientific discoveryEndpoints
  • 4h agoParakeet Health raises $10M to automate patient outreachEndpoints